Disseminated Langerhans cell histocytosis in children: Treatment outcome

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 2, 1999, Pages 180-183

  Kusumakumary, P ^a   James, F V ^a   Chellam, V G ^b   Ratheesan, K ^a   Nair, M K ^a  

^a REGIONAL CANCER CENTRE   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Complications; Langerhans cell histiocytosis; Prognosis; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINBLASTINE;

ADOLESCENT; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DISSEMINATED CANCER; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

6-MERCAPTOPURINE; ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; METHOTREXATE; PREDNISOLONE; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0033496047     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199904000-00016     Document Type: Article

References (23)

1. Writing group of histiocyte society. Histiocytosis syndrome in children. Lancet 1987;1:208-9.
2. Katz SI, Tamaki K, Sachs DH. Epidermal langerhans cells are derived from cells originating in bone marrow. Nature 1979;282: 324-6.
3. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy of disseminated langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:72-80.
4. Grundy P, Ellis R. Histiocytosis X: A review of etiology, pathology, staging and therapy. Med Pediatr Oncol 1986;14:45-50.
5. Raney RB, D'Angio GJ. Langerhan cell histiocytosis: experience at the Children's Hospital of Philadelphia. 1970-1984. Med Pediatr Oncol 1989;17:20-8.
6. Ceci A, Terlizzi M, Colella R, et al. Langerhans cell histiocytosis in childhood: results from the Italian co-operative AIEOP-CNR-Hx-83 study. Med Pediatr Oncol 1993;21:259-64.
7. Sims DG. Histiocytosis X. Follow up of 43 cases. Arch Dis Child 1977;52:433-40.
8. Mc Lelland J, Broadbent N, Yeomans E, Malone M, Pritchard J. Langerhans cell histiocytosis: the case for conservative treatment. Arch Dis Child 1990;65:301-3.
9. Lahey ME. Prognosis in reticuloenotheliosis in children. J Pediatr 1962;60:664-71.
10. Berry DH, Beclon DC. Natural history of histiocytosis X. Hematol Oncol Clin North Am 1987;1:23-34.
11. Janes B, Kung F, Chevalier L, et al. Chemotherapy of reticuloen-dotheliosis: comparison of methotrexate plus prednisolone vs vincristine plus prednisolone. Cancer 1974;34:1011-7.
12. Starling KA. Chemotherapy of histiocytosis. Am J Paediatr Hematol Oncol 1981;3:157-60.
13. Lavin TP, Osband ME. Evaluating the role of therapy in histiocytosis X: clinical studies, staging and scoring. Hematol Oncol Clin North Am 1987;1:35-47.
14. Nezelof CH, Frileux HF, Cronier SJ. Disseminated histiocytosis X. Analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979;44:1824-38.
15. Komp DM, El Malidi A, Starlin KA, et al. Quality of survival in histiocytosis. A southwest oncology group study. Med Pediatr Oncol 1980;8:35-40.
16. Gadner H, Beek JD, Janka GE, Kunl J. Histiocytosis. Diagnosis and treatment. Monogr Paediatr 1986;18:368-86.
17. Matus Ridley M, Rarey RB, Thawarani H, Meadows AT. Histiocytosis in children: patterns of disease and results of treatment. Med Pediatr Oncol 1983;11:99-105.
18. Osband ME. Immunotherapy of histiocytosis X. Hematol Oncol Clin North Am 1987;1:1131-46.
19. 2 receptor deficiency and successful treatment with thymic extract. N Engl J Med 1981;304:146-53.
20. Consolini R, Cini P, Cei B, Bottone E. Thynic dysfunction in histiocytosis X. Am J Pediatr Hematol Oncol 1987;9:146-9.
21. Sawamura M, Yawaguchi S, Murayama K, et al. Cyclosporine therapy for langerhans cell histiocytosis. Br J Hematol 1993;83: 178-9.
22. Mahmoud HM, Wang WE, Murphy SB. Cyclosporine therapy for advanced langerhans cell histiocytosis. Blood 1991;77:721-5.
23. Arico M, Colella R, Carer V, Indolfi P, et al. Cyclosporine therapy for refractory LCH. Med Pediatr Oncol 1995;25:12-6.